After years of relying on 5FU, colorectal cancer clinicians now have a wealth of targeted therapies and combination protocols to choose from. The question is, what to use in which patients and when?
Related Articles
Past events
Rome (Italy), 25-26/11/2016 – Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology
Senza categoria
NEWSROUND
Cutting Edge